This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chaiswing, L. Articles by Oberley, T. D. Search for Related Content PubMed PubMed Citation Articles by Chaiswing, L. Articles by Oberley, T. D.

¹ Department of Pathology and Laboratory Medicine, William S. Middleton Memorial Veterans Administration Hospital and University of Wisconsin Medical School, Madison, Wisconsin; ² Faculty of Medical Technology, Mahidol University, Bangkok, Thailand; ³ Department of Toxicology, University of Kentucky, Lexington, Kentucky; and ⁴ Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma

Requests for reprints: Terry D. Oberley, Department of Pathology and Laboratory Medicine, William S. Middleton Memorial Veterans Administration Hospital, Room A-35, 2500 Overlook Terrace, Madison, WI 53705. Phone: 608-256-1901 ext. 11722; Fax: 608-280-7087. E-mail: toberley{at}wisc.edu

In the present study, we used genetically engineered B6C3 mice [mice overexpressing manganese superoxide dismutase (TgM^+/+), mice in which inducible nitric oxide synthase had been inactivated (iNOSKO^–/–), and crosses of these two genotypes] to study the role of manganese superoxide dismutase (MnSOD) and inducible nitric oxide synthase (iNOS) in the development of acute Adriamycin-induced cardiotoxicity. Both nontransgenic and genetically engineered mice were treated with 20 mg/kg Adriamycin and cardiac left ventricular tissues studied at 0, 3, 6, and 24 hours. Ultrastructural damage and levels of 4-hydroxy-2-nonenal (4HNE) protein adducts and 3-nitrotyrosine (3NT) were determined in cardiomyocytes using immunogold ultrastructural techniques. Our previous results showed that Adriamycin caused mitochondrial injury without significant nuclear or cytoplasmic damage at early time points. Interestingly, overexpression of MnSOD protected against acute mitochondrial injury, whereas deficiency in iNOS potentiated mitochondrial injury in comparison with levels of injury present in cardiomyocyte mitochondria of nontransgenic mice. In TgM^+/+ mice, there was a significant inverse correlation between mitochondrial injury and 4HNE/3NT levels at all time points analyzed, suggesting that reactive oxygen species/reactive nitrogen species damage products directly regulated acute Adriamycin-induced mitochondrial injury in these mice. The present studies are the first to directly quantify the effects of MnSOD and iNOS on mitochondrial injury during acute Adriamycin-induced cardiotoxicity and show extensive and specific patterns of posttranslational modifications of mitochondrial proteins following Adriamycin treatment.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

⁵ http://www.r-project.org.

⁶ Supplementary material for this article is available at Molecular Cancer Therapeutics Online (http://mct.aacrjournals.org/).

Received 12/ 1/04; revised 4/14/05; accepted 4/29/05.